Add To Watchlist
Share URL
About The Company
CEO
Mr. Richard A. Gonzalez
Market Cap
293.34 Billion USD
Sector
Healthcare
Website
https://www.abbvie.comLast Update
2/22/2024, 12:00:00 PM
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.
Read More
Overview
Value
40
Growth
66
Health
50
Management
60
Analyst Opinion
94
Total
56
All Scores Out Of 100
Best Features
- Very strong cashflow and earnings growth
- Has a margin-of-safety above fair value
- Liked by analysts
- Has strong dividend growth
Risk Factors
- Earnings have declined recently
- There is a history of diluting shareholders
- Has a high level of debt
- Does not hold enough liquid assets to cover short term liabilities
- Disliked by Twitter users
- Price-to-earnings ratio of 65.4 is higher than the market average (19.6x)
- High preportion of income is paid as dividend
Market Peers
ABBV
Key Figures
PE Ratio (TTM)
65.37
Margin Of Safety (DCF)
63.16%
Revenue Growth (5 Year Average)
15.88%
Ratings Consensus
Strong Buy
Share Buybacks
-2.15%
Dividend Yeild (TTM)
3.32%
Valuation
Value Score
40
- ✔ Free-cashflow-yeild of 6.95% is better than the market average (4.7%)
- ✔ Margin-of-safety of 63.16% is better than the market average (17.95%)
- ✔ Estimated intrinsic-value of 293.32 USD is higher than current price ( 165.67 USD)
- ✘ Price-to-earnings ratio of 65.4 is higher than the market average (19.6x)
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 225.3 USD ✔
Current Price: 179.8 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
65.37x
Free Cashflow Yeild
6.95%
PE/Earnings Growth
25.74
Price/Book
30.54x
Growth
Growth Score
66
- ✔ 5 Year Average Revenue growth of 15.88% is higher than the market average (10.97%)
- ✔ 5 Year Average Earnings growth of 17.39% is higher than the market average (14.48%)
- ✔ 5 Year Average Cashflow growth of 18.24% is higher than the market average (12.35%)
- ✘ Revenue growth has slowed this year
- ✘ Earnings growth has slowed this year
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
15.88%
Earnings Growth
17.39%
Cashflow Growth
18.24%
Health
Health Score
50
Altman Z Score
2.18
Piostroski Score
7.00
Debt/Equity
3.67x
Current Assets/Liabilities
0.96x
Free Cashflow/Total Debt
0.38x
Debt/Capital
2.22x
Dividend
Secure Dividend Score
44
- ✔ Dividend yeild of 3.32% is more than the market average (1.85%)
- ✘ At risk of being unsafe
- ✔ Dividends have shown growth over the last 5 years
- ✘ Long term dividend payout ratio of 98.08% is high and may limit growth
- ✘ Payout ratio (TTM) of 216.72% is higher than the average (40%)
- ✘ Dividend growth has been slowing recently
- ✘ Spending a higher percentage of their income on dividends than last 5 years
Dividend Yeild
3.32%
Dividend Growth
8.44%
Payout Ratio (Earnings)
216.72%
Payout Ratio (Cashflow)
47.77%
Management
Management Score
60
- ✔ Has issued new shares to finance growth when share price is high
- ✔ Has returned higher dividends when earnings have risen
- ✔ Return-on-equity of 68.52% is higher than the market average (15%)
- ✔ Return-on-capital-employed of 16.85% is higher than the market average (10%)
- ✘ Has a history of diluting shareholders to finance activity
Average Buybacks/Dilution
-2.15%
Recent Buybacks/Dilution
-0.26%
5 Year Price Volitility
24.30%
Return On Assets
8.52%
Return On Capital Employed
16.85%
Return On Equity
68.52%
Return On Free Cashflow
N/A
Return On Investments
4395.00%
Analysts
Analyst Opinion
94
- ✔ Ratings consensus is Strong Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
AbbVie Inc.
Currency
USD
Beta
0.536202
Vol Avg
5768080
Ceo
Mr. Richard A. Gonzalez
Cik
0001551152
Cusip
00287Y109
Exchange
New York Stock Exchange
Full Time Employees
50000
Industry
Drug Manufacturers—General
Sector
Healthcare
Ipo Date
2013-01-02
Address
1 North Waukegan Road
City
North Chicago
State
IL
Country
US
Zip
60064-6400
Phone
847 932 7900
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
27
Twitter Sentiment
0.00
Stocktwits Sentiment
53.00